Keywords
Disabled Persons
Primary Health Care
Epidemiology
Health Profile
How to Cite
Abstract
The objective was to analyze the association between sociodemographic and clinical characteristics with the development of physical physical disabilities of grades 1 and 2 in people diagnosed with leprosy in Paraíba, Brazil. It’s an ecological study, population-based, which had the 223 municipalities at the Center of Chronic and Neglected Diseases/Leprosy belonging to the Health Surveillance Executive Management of Health Department of Paraíba State in June 2021, after extraction from the Notifiable Diseases Information System. The database gathered 2,468 new cases of leprosy registered in the period from 2016 to 2020. The probability of a person diagnosed with leprosy developing physical disability 1 or 2 is greater in males, aged 15 or over, formal education less than or equal to nine years, operational classification multibacillary, with more than five lesions and more than one affected nerve, in addition to positive bacilloscopy. Health education policies are strongly recommended in order to improve the knowledge of professionals and the community. Approaches about leprosy, early diagnosis, active search, surveillance and follow-up of cases and their contacts, in addition to physical disabilities, especially for people who are more vulnerable to develop them, are fundamental.
References
1. World Health Organization. Global leprosy (Hansen disease) update, 2021: moving towards interruption of transmission. Wkly Epidemiol Rec [Internet]. 2022 Sep[updated 2022; cited 2022 Oct 20]97(36):429-52. Available from: https://www.who.int/publications/i/item/who-wer9736-429-450.
2. Morais JR, Lustosa-Furtado ÉZ. Grau de incapacidade física de pacientes com hanseníase. Rev. enferm. UFPE on line. 2018 jun. 2;12(6):1625-32. doi: https://doi.org/10.5205/1981-8963-v12i6a231049p1625-1632-2018.
3. Alves GMG, Almeida AGCS, Licetti MM, Costa CMO, Araújo KCGM. Relevance of the degree of physical disability as a predictor of late diagnosis in leprosy: a scoping review. Res. Soc. Dev. 2021 May 21;10(6):e5410615399. doi: https://doi.org/10.33448/rsd-v10i6.15399.
4. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Coordenação Geral de Desenvolvimento da Epidemiologia em Serviços. Guia de Vigilância em Saúde. 3 ed. Brasília: Ministério da Saúde; 2019. [acesso em 10 fev. 2022]. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_3ed.pdf.
5. Ministério da Saúde (BR) [Internet]. Informações em Saúde DATASUS. Brasília: MS; 2021 [atualizado em 2022; Acesso em 04 set. 2022]. Casos de Hanseníase – desde 2001 (SINAN): acompanhamento dos dados de hanseníase; [aproximadamente 1 página]. Disponível em: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/hanswbr.def.
6. Paz WP, Souza MR, Tavares DS, Jesus AR, Santos AD, Carmo RF, et al. Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: an ecological and population-based study. Lancet Reg Health Am. 2022 May;9:100181. doi: https://doi.org/10.1016/j.lana.2021.100181.
7. Organização Pan Americana de Saúde [Internet]. Washington: OPAS/OMS; 2021. [atualizado em 22 jan. 2022; acesso em 08 nov. 2022]. Doenças tropicais negligenciadas: OPAS pede fim dos atrasos no tratamento nas Américas; [aproximadamente 2 páginas]. Disponível em: https://www.paho.org/pt/noticias/28-1-2022-doencas-tropicais-negligenciadas-opas-pede-fim-dos-atrasos-no-tratamento-nas.
8. BRASIL. Ministério da Saúde. Conselho Nacional de Saúde. Comissão Nacional de Ética em Pesquisa – CONEP. Normas para pesquisas envolvendo seres humanos: resolução CNS466/12. Diário Oficial [da] República Federativa do Brasil, Brasília, DF, 13 de junho de 2013. Seção 1, p. 59. Disponível em: https://conselho.saude.gov.br/resolucoes/2012/Reso466.pdf. Acesso em: 15 nov. 2022.
9. BRASIL. Ministério da Saúde. Conselho Nacional de Saúde. Resolução nº 510, de 7 de abril de 2016. Diário Oficial [da] República Federativa do Brasil, Brasília, DF, 24 maio 2016. Seção 1. p. 44-46. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2016/res0510_07_04_2016.html. Acesso em: 15 nov. 2022.
10. Movimento de Reintegração das Pessoas Atingidas pela Hanseníase [Internet]. Rio de Janeiro: MORHAN; c2011. [atualizado em 18 jan. 2022; acesso em 08 nov. 2022]. No Brasil, campanha global “Não esqueça da hanseníase” ganha fôlego à medida que o Dia Mundial da Hanseníase se aproxima; [aproximadamente 1 página]. Disponível em: http://www.morhan.org.br/noticias/2553/no_brasil_campanha_global_%E2%80%
11. Martins BC, Nascimento ES, Coelho VAT, Souza CG, Bigatello CS, Sobral LT. Caracterização das incapacidades físicas em pacientes diagnosticados com hanseníase multibacilar Almenara-MG. Id on Line Rev. Mult. Psic. 2020 out.;14(52):924-35. doi: https://doi.org/10.14295/idonline.v14i52.2770.
12. Sanchez MN, Nery JS, Pescarini JM, Mendes AA, Ichihara MY, Teixeira CSS, et al. Physical disabilities caused by leprosy in 100 million cohort in Brazil. BMC Infect Dis. 2021;21(1):290. doi: https://doi.org/10.1186/s12879-021-05846-w.
13. Heidinger M, Simonnet E, Karippadathu SF, Puchinger M, Pfeifer J, Grisold A. Analysis of social determinants of health and disability scores in leprosy-affected persons in Salem, Tamil Nadu, India. Int J Environ Res Public Health. 2018;15(12):2769. doi: https://doi.org/10.3390/ijerph15122769.
14. Srinivas G, Muthuvel T, Lal V, Vaikundanathan K, Schwienhorst-Stich EM, Kasang C. Risk of disability among adult leprosy cases and determinants of delay in diagnosis in five states of India: a case-control study. PLoS Negl Trop Dis. 2019;13(6):e0007495. doi: https://doi.org/10.1371/journal.pntd.0007495.
15. Paula HL de, Souza CDF de, Silva SR, Martins PRS Filho, Barreto JG, Gurgel RQ, et al. Risk factors for physical disability in patients with leprosy: a systematic review and meta-analysis. JAMA Dermatol. 2019 Oct 1;155(10):1120-8. doi: https://doi.org/10.1001/jamadermatol.2019.1768.
16. Alencar L, Cunha M. Hansen’s disease in Brazil: monitoring of disabilities. Millenium [Internet]. 2017 [cited 2022 Jul 11];2(3):61-71. Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=7841622.
17. World Health Organization [Internet]. Geneva: OMS; 2022. [updated 2022; cited 2022 Sep 20]. Leprosy; [about 1 screen]. Available from: https://www.who.int/news-room/fact-sheets/detail/leprosy.
18. World Health Organization. Towards zero leprosy: global leprosy (Hansen’s Disease) strategy 2021-2030 [Internet]. Índia: OMS; 2021. [updated 2021; cited 2022 Sep 20]. Available from: https://www.who.int/publications/i/item/9789290228509.
19. Carvalho RA, Alencar JLG, Souza SM, Araújo VNB, Monteiro LD. Physical disabilities of hanseníasis in children under 15 in the state of Tocantins, Brazil, 2001 to 2020. Res Soc Dev. 2022;11(5):e18311527995. doi: https://doi.org/10.33448/rsd-v11i5.27995.
20. Guthi VR, Arepalli S, Ganapa P. Study of socio demographic factors among persons affected by leprosy in Kurnool division of Kurnool district, Andhra Pradesh, India. Int J Community Med Public Health. 2016;3(12):3548-55. doi: http://dx.doi.org/10.18203/2394-6040.ijcmph20164290.
21. Ribeiro GC, Lana FCF. Physical disabilities in leprosy: characterization, factors related and evolution. Cogitare Enferm [Internet]. 2015 [cited 2022 Sep 20];20(3):495-502. Available from: https://revistas.ufpr.br/cogitare/article/view/41246/26190.
22. Silva JRS, Palmeira IP, Sá AMM, Nogueira LMV, Ferreira AMR. Sociodemographic factors associated with the degree of physical disability in leprosy. Rev. cuid. 2018 Sep-Dec;9(3):2338-48. doi: https://doi.org/10.15649/cuidarte.v9i3.548.
23. Véras GCB, Lima JF Júnior, Cândido EL, Maia ER. Risk factors for physical disability due to leprosy: a case-control study. Cad Saúde Colet. 2021;29(3):411-23. doi: https://doi.org/10.1590/1414-462X202129030182.
24. Instituto Brasileiro de Geografia e Estatística [Internet]. Brasília: IBGE; 2022. [atualizado em 2022; acesso em 10 set. 2022]. Cidades e Estados/Paraíba; [aproximadamente 1 página]. Disponível em: https://www.ibge.gov.br/cidades-e-estados/pb/.
25. World Health Organization. Leprosy/Hansen Disease: management of reactions and prevention of disabilities: technical guidance [Internet]. Índia: OMS; 2020 [cited 2022 Sep 20]. Available from: https://www.who.int/publications/i/item/9789290227595.
26. Uchôa REMN, Brito KKG de, Santana EMF. Clinical profile and physical disabilities in patients with leprosy. J Nurs UFPE on line. 2017 [cited 2022 Nov 15];11(Suppl. 3):1464-72. Available from: https://periodicos.ufpe.br/revistas/revistaenfermagem/article/view/
27. Silva JSR, Palmeira IP, Sá AMM, Nogueira LMV, Ferreira AMR. Variáveis clínicas associadas ao grau de incapacidade física na hanseníase. Rev Cuid. 2019;10(1):e618. doi: http://dx.doi.org/10.15649/cuidarte.v10i1.618.
28. Henry M, Galan N, Teasdale K, Prado R, Amar H, Rays MS, et al. Factors contributing to the delay in diagnosis and continued transmission of leprosy in Brazil: an explorative, quantitative, questionnaire based study. PLoS Negl Trop Dis. 2016 Mar 15;10(3):e0004542. doi: https://doi.org/10.1371/journal.pntd.0004542.
29. Jardim R, Reis AS, Schott M, Santos DO. Atuação profissional e condições de trabalho na atenção primária à saúde no interior do nordeste brasileiro. RECIMA 21: Rev Cient Mult. 2022;3(3):e331196. doi: https://doi.org/10.47820/recima21.v3i3.1196.
30. Santos AR, Ignotti E. Prevenção de incapacidade física por hanseníase no Brasil: análise histórica. Cien Saude Colet. 2020;25(10):3731-44. doi: https://doi.org/10.1590/1413-812320202510.30262018.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Gerlane Cristinne Bertino Véras, Luiz Henrique da Silva, Wagner Maciel Sarmento, Ronei Marcos de Moraes, Simone Helena dos Santos Oliveira, Maria Júlia Guimarães Oliveira Soares
Downloads
